Centenary Institute Facebook Centenary Institute Centenary Institute Centenary Institute Centenary Institute
Home » About us » Media Centre » Latest News » Media Releases 2012 » Young researcher taking fight against global killer to the next level in Vietnam

Young researcher taking fight against global killer to the next level in Vietnam

An Australian scientist will bring effective screening for tuberculosis (TB) a step closer with his latest study in Vietnam- where he now lives and works.We still don’t know why only one in ten of the two billion people carrying the Mycobacteria tuberculosis bacterium become sick with tuberculosis (TB). But the disease kills more than one million people worldwide every year – three every minute.

Centenary Institute researcher Dr Greg Fox is helping to find out by using a $150,000 grant from an anonymous benefactor to conduct a genetic
study of TB patients and their families in Vietnam, a country where
290,000 people have TB and 54,000 die from it every single year.

The role of genes in the risk of contracting TB is thought to be about 30-40 per cent – Greg wants to find out more.

“By studying the genetics of those who live in a country with high
rates of TB, we can compare genetic differences between those affected
by TB and those who aren’t,” Greg says, “This may one day allow us to
screen those with a high likelihood of being exposed to TB.”

Greg has worked with TB patients and their families in Vietnam for the
past three years at the National Lung Hospital in Hanoi.

For this project and a range of other projects, Greg is collaborates
with the National Lung Hospital in Hanoi and the Pham Ngoc Thac Hospital
in Ho Chi Minh City as part of Vietnam’s National Tuberculosis program.

His other research project, which will continue until 2014, is part of
a $1.3m NHMRC-funded collaboration between Centenary and the Woolcock
Institute
that set up a controlled trial of active screening of TB patient’s
family members in 71 District Clinics in eight provinces across Vietnam.

This experience reminds Greg why he and Centenary have committed to
strengthening both treatment and research efforts in the developing
world.

“Being in Vietnam, with my wife and young son, I’m constantly
reminded about the importance of TB research and establishing
partnerships with countries that have high levels of this devastating
disease,” he says.

“In Vietnam, tuberculosis most often affects the poor. If we can
develop better ways of combatting this disease, then it will make a real
difference to those who are least able to afford it.”

“My wife, who is a GP working at an international clinic, and I
are grateful that we are in positions to make a difference to such a
major health problem.”

Centenary Institute is also conducting a genetic study in China, another country with a high incidence of TB.

Dr Magda Ellis is analysing thousands of genetic samples for the
biggest genome-wide study of TB patients ever conducted in Asia, which
will complement the work being done in Vietnam.

“TB is a global disease that requires global solutions,
“Professor Mathew Vadas, the Director of the Centenary Institute says,

“Greg’s efforts in Vietnam complement our other genetic study in China
and of course, our core team here in Sydney working on new drugs and
vaccines for TB.”

- End -

Click here to download a PDF of the complete media release and backgrounder.

Clich here to read more about Greg’s work.

Learn more about tuberculosis.

For interviews contact:

- Niall Byrne, Science in Public, 0417 131 977,niall@scienceinpublic.com.au or

- Suzie Graham on (02) 9565 6166

Greg is in Sydney for the next few months before returning to Vietnam.

Res_GM1

Iconic-pill


ABN 22 654 201 090 has Deductible Gift Recipient (DGR) status with the Australian Tax Office. 
© 2014 Centenary Institute of Cancer Medicine and Cell Biology.